Insiders · Profile

Grund Nicholas

Chief Commercial Officer at Akebia Therapeutics. Filing since 3 Feb 2025. CIK 0001661887

Company
Date
Role
Action
Shares
Amount
Of holding
2 Feb 2026
Chief Commercial Officer
Sold on a plan
84,829
$117.91K
13.1%
3 Feb 2025
Chief Commercial Officer
Sold on a plan
55,621
$116.80K
11.2%
2 decisions on file.